Novo Nordisk Pharmatech A/S
Københavnsvej 216, 4600 Køge, CVR 13246149
Score
Score panel requires Premium access
Rank Profit for the Year
Rank in industry
5/118
"Top 10%"
Rank in Denmark
1,066/297,141
"Top 10%"
Top management Top 3
Board Top 3
Henrik Ehlers Wulff 3 | Chairman of board |
Henrik Kaj Dvinge 2 | Boardmember |
Joachim Juel Hagemeister 1 | Boardmember |
Legal owners Top 3
100% | Novo Nordisk A/S |
Rights certificate
Selskabet tegnes af bestyrelsesformanden og direktøren i forening eller af bestyrelsesformanden og 1 medlem af bestyrelsen i forening eller af 3 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse
Company information based on CVR
Name | Novo Nordisk Pharmatech A/S |
---|---|
CVR | 13246149 |
Address | Københavnsvej 216, 4600 Køge |
Industry | Manufacture of pharmaceutical preparations [212000] |
Established | 01-07-1989 (30 yr) |
Company Type | Limited Corporation |
Number of employees | 170 (Fin.Stmt) |
Advertising protection | No |
Auditor | Pricewaterhousecoopers Statsautoriseret Revisionspartnerselskab |
Financial statement period | 01-01 to 31-12 |
Company capital | 10,000,000 DKK 5,000,000 DKK (31-05-1990 - 25-01-1994) 300,000 DKK (20-07-1989 - 30-05-1990) |
Articles of assoc. last | 28-08-2015 |
Member of industries
- Manufacture of pharmaceutical preparationsNACE6 containing 213 comp.
- Manufacture of pharmaceutical preparationsNACE3 containing 213 comp.
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE2 containing 257 comp.
- ManufacturingNACE1 containing 26,515 comp.
Purpose
Selskabets formål er at drive handel og industri
Financial Statement
2018 | 2017 | 2016 | |
---|---|---|---|
Currency/unit | 000' DKK | 000' DKK | 000' DKK |
Revenue | 690,700 +11% | 622,436 -7% | 669,077 +32% |
Gross Profit | 283,278 +8% | 263,449 +11% | 237,950 +4% |
Profit for the Year | 105,268 +2% | 103,665 +19% | 87,367 -5% |
Equity | 614,221 +16% | 528,953 +13% | 468,288 +17% |
Total Assets | 760,808 +12% | 676,372 +3% | 653,833 +6% |
Map
Loading...